David Mountcastle - Executive VP, CFO & Principal Accounting Officer
Parth Mehrotra - CEO & Director
Robert P. Borchert - Senior Vice President of Investor Relations & Corporate Communications
Conference Call Participants
Albert J. William Rice - UBS Investment Bank, Research Division
Andrew Mok - Barclays Bank PLC, Research Division
Craig Jones - BofA Securities, Research Division
Daniel R. Grosslight - Citigroup Inc., Research Division
Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division
Jack Garner Slevin - Jefferies LLC, Research Division
Jailendra P. Singh - Truist Securities, Inc., Research Division
Jeffrey Robert Garro - Stephens Inc., Research Division
Jenny Shen - BTIG, LLC, Research Division
Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division
Joshua Richard Raskin - Nephron Research LLC
Matthew Dale Gillmor - KeyBanc Capital Markets Inc., Research Division
Matthew Dineen Shea - Needham & Company, LLC, Research Division
Olivia Shea Miles - Robert W. Baird & Co. Incorporated, Research Division
Richard Collamer Close - Canaccord Genuity Corp., Research Division
Ryan M. Langston - TD Cowen, Research Division
Ryan Scott Daniels - William Blair & Company L.L.C., Research Division
Tao Qiu - Macquarie Research
Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Privia Health Second Quarter 2025 Conference Call. [Operator Instructions]
I would now like to turn the conference over to Robert Borchert, SVP of Investor and Corporate Communications. You may begin.
Robert P. Borchert
Thank you, Desiree, and good morning, everyone. Joining me are Parth Mehrotra, our Chief Executive Officer; and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed in the Investor Relations